ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1450

Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-based Cohort of Patients with Rheumatoid Arthritis

Elizabeth Atkinson1, Tina Gunderson1, John Davis1, Elena Myasoedova1, Vanessa Kronzer1, Caitrin Coffey1 and Cynthia Crowson2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

Meeting: ACR Convergence 2021

Keywords: Comorbidity, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Abstracts: Clinical Epidemiology (1446–1451)

Session Type: Abstract Session

Session Time: 3:00PM-3:15PM

Background/Purpose: Comorbidities are common in patients with rheumatoid arthritis (RA), and comorbidity patterns are of interest. We aimed to examine clusters of comorbidities and clusters of patients based on comorbidities using several methods.

Methods: In this retrospective, population-based study, residents of a geographically well-defined area with prevalent RA on 1-1-2015 were identified from a comprehensive medical record linkage system. Diagnostic codes were retrieved for a 5 year period prior to the prevalence date. Using 2 codes at least 30 days apart, the 44 comorbidities described by England et al (ARD 2020) were defined. Unsupervised machine learning methods of interest included ascendant hierarchical clustering, network analysis, partitioning around medoids and latent class analysis. Methodologic considerations include the research question of interest, whether the method is appropriate for categorical data, method assumptions (e.g., some methods assume equal sample size per cluster), the optimal number of clusters, internal validation, stability and biological plausibility.

Results: A total of 1409 patients with prevalent RA (72% female; 92% white; mean age 63.5 years) were studied. Comorbidities were present in 1187 (84%) of the subjects with 5+ comorbidities present in 749 (53%) subjects.

Clustering of comorbidities using hierarchical clustering methods yielded 8 clusters (Figure 1a) while network analysis (Figure 1b) yielded 4 clusters. In both methods, the clusters were primarily organized around body systems (e.g., cardiovascular, respiratory, mental/behavioral comorbidities) with greater stability between methods for comorbidities with higher prevalence than those that were less common. Figure 2 illustrates the prevalence of each comorbidity within the cohort, grouped according to the clusters identified using the hierarchical approach.

Clustering of patients into subgroups based on comorbidity profiles using partitioning around medoids and latent class analysis yielded groups with no/few comorbidities, many comorbidities, and 2-3 intermediate groups with some comorbidities. Figure 3 shows the prevalence of each comorbidity within the 4 clusters identified using latent class analysis.

Conclusion: Clustering of comorbidities and clustering of patients can provide useful information about multimorbidity patterns in patients with RA. Clustering variables allows for easy application to other cohorts (e.g., non-RA). Clustering of RA subjects primarily created groups of subjects who had varying numbers of comorbidities. Various clustering methods are available, and these methods yield different results. It is important to understand the assumptions of these methods, as well as how to determine the optimal number of clusters for each method. Further research is needed to determine the best methods for identifying comorbidity patterns in RA.


Disclosures: E. Atkinson, None; T. Gunderson, None; J. Davis, Pfizer, 5; E. Myasoedova, None; V. Kronzer, None; C. Coffey, None; C. Crowson, None.

To cite this abstract in AMA style:

Atkinson E, Gunderson T, Davis J, Myasoedova E, Kronzer V, Coffey C, Crowson C. Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-based Cohort of Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/unsupervised-machine-learning-methods-to-cluster-comorbidities-in-a-population-based-cohort-of-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unsupervised-machine-learning-methods-to-cluster-comorbidities-in-a-population-based-cohort-of-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology